Clinician-reviewed CDS · Browser-local · No identifiers · Source-linkedRead more…
This tool is educational and informational. It does not replace clinical judgment. Verify trial populations, sICH definitions, BP target ranges, and post-treatment monitoring against the cited source before acting.
Not prospectively validated. No clinical tool replaces bedside assessment.
This tool qualifies as non-device clinical decision support under the January 2026 FDA CDS guidance (21st Century Cures Act §3060). It does not acquire or analyze patient data, it displays the basis for its recommendations, it enables independent clinician review, and it is intended for use by trained healthcare professionals.
This runs entirely in your browser; we store nothing. Even so, enter only clinical data (age, vitals, exam findings) -- not names, MRNs, or other identifiers.
Tarvinder Singh, MD -- Vascular Neurologist. March 2026.
Acute Ischemic Stroke
IVT and EVT eligibility by time window, imaging, and contraindication profile against AHA/ASA 2026 guidelines and stroke trial evidence.
Safety flags -- check any that apply
Step 1: Hyperacute Screen
BP < 185/110 After Treatment Attempt?
This is the only BP question the IVT gate needs here. Use Yes once the pressure is below threshold after treatment or clearly controllable with IV antihypertensives.
Step 1b: Lab Gate
Common IVT lab blockers still need review.
Glucose (mg/dL)
Platelets (K/uL)
INR
Step 1c: Imaging And Transfer Refinement
What To Enter Next
Start with the core IVT screen fields.
Core IVT Screen
EVT And Evidence Refinement
Transfer And Workflow
IV Thrombolysis (IVT)
Awaiting core screen data
Start with age, last known well, NIHSS, CT head result, and whether BP is below 185/110 after treatment.
Mechanical Thrombectomy (EVT)
Awaiting core screen data
Then add vessel imaging, ASPECTS, and transfer capability to tighten EVT candidacy and evidence support.